A 505(b)(2) product is an improved or altered version or a new use application for a previously FDA-approved drug. This unique regulatory pathway, available only for marketing approval in the US, offers an attractive pathway to cheaper and faster new drug development, particularly to a manufacturer with experience in developing generic products.
Webinar On - Improved Generic Drugs via the 505(b)(2) Regulatory Pathway: FDA Approval Made Easy
19 February 2014, Mississauga, Canada
Introduction
Venue
Online
Online, 5939 Candlebrook Ct,, Ontario, Mississauga, L5V 2V5, Canada
Useful links
Contact information
Related events
7th International Conference on Nanomaterials Science and Mechanical Engineering
8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
21st RSC Nucleic Acids Forum 鈥� 2025
11 July 2025 10:00-18:00, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
